Hiroaki Iijima

2.9k total citations
64 papers, 2.4k citations indexed

About

Hiroaki Iijima is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Hiroaki Iijima has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Hiroaki Iijima's work include Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (17 papers) and Diabetes Management and Research (12 papers). Hiroaki Iijima is often cited by papers focused on Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (17 papers) and Diabetes Management and Research (12 papers). Hiroaki Iijima collaborates with scholars based in Japan, United States and Spain. Hiroaki Iijima's co-authors include Tokuo Yamamoto, Nobuya Inagaki, Hiroyuki Suzuki, Nobuko Maruyama, Takahiro Fujino, Hiroshi Imahori, Seigo Ito, Yoshihiro Matano, Tomokazu Umeyama and Juro Sakai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Hiroaki Iijima

61 papers receiving 2.4k citations

Peers

Countries citing papers authored by Hiroaki Iijima

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Iijima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Iijima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Iijima more than expected).

Fields of papers citing papers by Hiroaki Iijima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Iijima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Iijima. The network helps show where Hiroaki Iijima may publish in the future.

Co-authorship network of co-authors of Hiroaki Iijima

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Iijima. A scholar is included among the top collaborators of Hiroaki Iijima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Iijima. Hiroaki Iijima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases 2024 ·Diabetes Obesity and Metabolism ·Hiroaki Iijima, M. Wafik Gouda, (unknown), (unknown), Akiko Takahashi, (unknown), Hideki Ninomiya, (unknown), Atsushi Miyawaki, Jun Wada	1
2	Combined treatment with teneligliptin and canagliflozin additively suppresses high-fat diet-induced body weight gain in mice with modulation of lipid metabolism-related gene expression 2023 ·European Journal of Pharmacology ·(unknown), (unknown), Hiroaki Iijima, Haruya Takahashi, Wataru Nomura, Kazuo Inoue, Teruo Kawada, Tsuyoshi Goto	0
3	<p>Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism</p> 2020 ·Diabetes Metabolic Syndrome and Obesity ·(unknown), (unknown), Hiroaki Iijima, (unknown), (unknown), (unknown), (unknown), Huei‐Fen Jheng, Haruya Takahashi, Wataru Nomura, Kazuo Inoue, Teruo Kawada, Tsuyoshi Goto	5
4	<p>Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes</p> 2020 ·Diabetes Metabolic Syndrome and Obesity ·Mitsuyoshi Takahara, Toshihiko Shiraiwa, Taka‐aki Matsuoka, Kaoru Yamamoto, Yoshifumi Maeno, (unknown), Yoko Yoshida, Naoto Katakami, Hiroaki Iijima, (unknown), Kenji Arakawa, Toshio Hashimoto, Iichiro Shimomura	1
5	Serum level of soluble interleukin‐2 receptor is positively correlated with metabolic tumor volume on ¹⁸F‐FDG PET/CT in newly diagnosed patients with diffuse large B‐cell lymphoma 2019 ·Cancer Medicine ·Hajime Senjo, Minoru Kanaya, Koh Izumiyama, Koichiro Minauchi, Kenji Hirata, Akio Mori, Makoto Saito, Masanori Tanaka, Hiroaki Iijima, Eriko Tsukamoto, Kazuo Itoh, Shuichi Ota, Masanobu Morioka, Daigo Hashimoto, Takanori Teshima, (unknown)	10
6	Early prediction of lenvatinib treatment efficacy by using ¹⁸ F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study 2018 ·BMJ Open ·Satoshi Takeuchi, Tohru Shiga, Kenji Hirata, Jun Taguchi, Keiichi Magota, (unknown), (unknown), (unknown), (unknown), Yasushi Shimizu, Ichiro Kinoshita, Yasushi Tsuji, Akihiro Homma, Hiroaki Iijima, Nagara Tamaki, Hirotoshi Dosaka‐Akita	7
7	Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus 2018 ·Diabetes Metabolic Syndrome and Obesity ·M. Wafik Gouda, (unknown), Hiroaki Iijima	28
8	Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus 2016 ·Cardiovascular Diabetology ·Nobuya Inagaki, Shin‐ichi Harashima, Nobuko Maruyama, Yutaka Kawaguchi, Maki Goda, Hiroaki Iijima	60
9	Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies 2015 ·Expert Opinion on Pharmacotherapy ·Takashi Kadowaki, (unknown), (unknown), Makoto Katoh, Hiroaki Iijima	31
10	Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus 2015 ·Advances in Therapy ·Nobuya Inagaki, Maki Goda, (unknown), Nobuko Maruyama, Hiroaki Iijima	24
11	An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study 2011 ·BMC Medical Genetics ·Hironori Masuko, Tohru Sakamoto, (unknown), Hiroaki Iijima, Takashi Naito, Emiko Noguchi, Tomomitsu Hirota, Mayumi Tamari, Nobuyuki Hizawa	33
12	NOS 1 Is Required for Allergen-Induced Expression of NOS 2 in Mice 2005 ·International Archives of Allergy and Immunology ·Hiroaki Iijima, Meri K. Tulić, Alexandre Duguet, Jichuan Shan, (unknown), Qutayba Hamid, David H. Eidelman	20
13	The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3) 2004 ·Journal of Peptide Science ·Robert G. Boyle, John Eric Humphries, T. Andrew Mitchell, Graham A. Showell, (unknown), Hiroaki Iijima, Hiroshi Shimada, (unknown), Hiroaki Ueno, (unknown), (unknown), Etsuko Wada, Keiji Wada	17
14	Chlorine-induced Injury to the Airways in Mice 2003 ·American Journal of Respiratory and Critical Care Medicine ·James G. Martin, Holly R. Campbell, Hiroaki Iijima, Denyse Gautrin, Jean‐Luc Malo, David H. Eidelman, Qutayba Hamid, Karim Maghni	129
15	Ebselen suppresses late airway responses and airway inflammation in guinea pigs 2002 ·Free Radical Biology and Medicine ·Minjie Zhang, Akihiro Nomura, Yoshiyuki Uchida, Hiroaki Iijima, Tohru Sakamoto, (unknown), Yuko Morishima, M. Mochizuki, Kuniko Masuyama, (unknown), Kiyohisa Sekizawa	50
16	Expression and Characterization of a Very Low Density Lipoprotein Receptor Variant Lacking the O-Linked Sugar Region Generated by Alternative Splicing 1998 ·The Journal of Biochemistry ·Hiroaki Iijima, Masaaki Miyazawa, Juro Sakai, Kenta Magoori, Makiko Ito, Hiroshi Suzuki, M Nose, Yutaka Kawarabayasi, Tokuo Yamamoto	49
17	Nitrogen Dioxide Exposure Increases Airway Contractile Response to Histamine by Decreasing Histamine N-Methyltransferase Activity in Guinea Pigs 1996 ·American Journal of Respiratory Cell and Molecular Biology ·Hideo Hoshi, Katsuya Yamauchi, Kiyohisa Sekizawa, Yuichi Ohkawara, Hiroaki Iijima, Eiko Sakurai, K Maeda, Shoji Okinaga, (unknown), Masashi Honma, G Tamura, Yasuo Tanno, Tsuyoshi Watanabe, H. Sasaki, K Shirato	5
18	Human Apolipoprotein E Receptor 2 1996 ·Journal of Biological Chemistry ·Dong-Ho Kim, Hiroaki Iijima, Kaoru Goto, Juro Sakai, Hirofumi Ishii, (unknown), Hiroyuki Suzuki, Hisatake Kondo, Shigeru Saeki, Tokuo Yamamoto	329
19	The Role of the Very Low Density Lipoprotein Receptor in the Metabolism of Plasma Lipoproteins Containing ApoE^a 1994 ·Annals of the New York Academy of Sciences ·Tokuo Yamamoto, Atsushi Hoshino, Sadao Takahashi, Yutaka Kawarabayasi, Hiroaki Iijima, Juro Sakai	7
20	Bronchoalveolar Lavage and Histologic Characterization of Late Asthmatic Response in Guinea Pigs 1987 ·American Review of Respiratory Disease ·Hiroaki Iijima, Masayuki Ishii, Kunihiko Yamauchi, (unknown), Kôichi Kimura, Sanae Shimura, (unknown), Hiroshi Inoue, (unknown), T Takishima	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact